Expression of a receptor protein tyrosine phosphatase in human glial tumors

Journal of Neuro-Oncology

Volumn 36, Issue 3, 1998, Pages 209-217

  Norman, Sylvia A ^a   Golfinos, John G ^b   Scheck, Adrienne C ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Astrocytomas; Gliomas; Protein tyrosine phosphatase; Receptor phosphatase; RT PCR

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031931118     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005840420136     Document Type: Article

References (36)

1. Sun H, Tonks NK: The coordinated action of protein tyrosine phosphatases and kinases in cell signaling. Trends Biochem Sci 19: 480-485, 1994
2. Hunter T: Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80: 225-236, 1995
3. Brown-Shimer S, Johnson KA, Hill DE, Bruskin AM: Effect of protein tyrosine phosphatase 1B expression by the human neu oncogene. Cancer Res 52: 478-482, 1992
4. Zhai Y, Beittenmiller H, Bingcheng W, Gould MN, Oakley C, Esselman WJ, Welsch CW: Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 53: 2272-2278, 1993
5. Laforgia, S.Morse B, Levy J, Barnea G, Cannizzaro LA, Li F, Nowell PC, Boghosian-Sell L, Glick J, Weston A, Harris CC, Drabkin H, Patterson D, Croce CM, Schlessinger J, Huebner K: Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci USA 88: 5036-5040, 1991
6. Barnea G, Silvennoinen I, Shaanan B, Honegger AM, Canoll PD, D'Eustachio P, Morse B, Levy JB, Laforgia S, Huebner K, Musacchio JM, Sap J, Schlessinger J: Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases. Mol Cell Biol 13: 1497-1506, 1993
7. Krueger NX, Saito H : A human transmembrane protein-tyrosine-phosphatase, PTP zeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases. Proc Natl Acad Sci USA 89: 7417-7421, 1992
8. Levy JB, Canoll PD, Silvennoinen O, Barnea G, Morse B, Honegger AM, Huang JT, Cannizzaro LA, Park S-H, Druck T, Huebner K, Sap J, Ehrlich M, Musacchio JM, Schlessinger J: The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system. J Biol Chem 268: 10573-10581, 1993
9. Barnea G, Grumet M, Sap J, Margolis RU, Schlessinger J: Close similarity between receptor-linked tyrosine phosphatase and rat brain proteoglycan. Cell 76: 205, 1993
10. Canoll PD, Barnea G, Levy JB, Sap J, Ehrlich M, Silvennoinen O, Schlessinger J, Musacchio JM: The expression of a novel receptor-type tyrosine phosphatase suggests a role in morphogenesis and plasticity of the nervous system. Develop Brain Res 75: 293-298, 1993
11. Grumet M, Flaccus A, Margolis RU: Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules. J Cell Biol 120: 815-824, 1993
12. Barnea G, Grumet M, Milev P, Silvennoinen O, Levy JB, Sap J, Schlessinger J: Receptor tyrosine phosphatase β is expressed in the form of proteolycan and binds to the extracellular protein tenascin. J Biol Chem 269: 14349-14352, 1994
13. Grumet M, Milev P, Sakurai T, Karthikeyan L, Bourdon M, Margolis RK, Margolis RU: Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. Am Soc Biochem Mol Biol Inc 269: 12142-12146, 1994
14. Grumet M: Cell adhesion molecules and their subgroups in the nervous system. Curr Opin Neurobiol 1: 370-376, 1991
15. Margolis RK, Margolis RU: Nervous tissue proteoglycans. Exp 49: 429-446, 1993
16. Bourdon MA, Ruoslahti E: Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 108: 1149-1155, 1989
17. Riou J, Shi D, Chiquet M, Boucaut J: Exogenous tenascin inhibits migration during amphibian gastrulation. Dev Biol 137: 305-317, 1990
18. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I: Tenascin in normal, reactive, hyperplastic and neoplastic tissues; biologic and pathologic implications. Hum Pathol 22: 636-643, 1991
19. Mackie EJ, Chiquet-Ehrisman R, Pearson CA, Inaguma Y, Taya K, Kawarada Y, Sakakura T: Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA 84: 4621-4625, 1987
20. Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T: Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol 85: 481-487, 1993
21. Erickson HP, Bourdon MA: Tenascin: An extracellular matrix protein prominent in specialized embryonic tissues and tumors. Ann Rev Cell Biol 5: 71-92, 1989
22. Zagzag D, Friedlander DR, Miller DC, Dosik J, Cangiarella J, Kostianovsky M, Cohen H, Grumet M, Greco MA: Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 55: 907-914, 1995
23. Burger PC, Scheithauer BW, Vogel FS: Brain: Tumors. In: Burger PC, Scheithauer BW, Vogel FS (eds) Surgical Pathology of the Nervous System and its Coverings. 3rd ed. Churchill Livingstone, New York, 1991, pp 194-404
24. Kleihues P, Burger PC, Scheithauer BW: Histologic Typing of Tumours of the Central Nervous System. New York: Springer-Verlag; 1993
25. Earnest F, Kernohan J, Craig W: Oligodendrogliomas. A review of two hundred cases. Arch Neurol Psychiatry 63: 964-976, 1950
26. Coons SW, Johnson PC, Shapiro JR: Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade glioma. Cancer Res 55: 1569-1577, 1995
27. James CD, Collins VP: Molecular genetic characterization of CNS tumor oncogenesis. Adv Cancer Res 58: 121-142, 1992
28. Scheck AC, Coons SW: Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res 53: 5605-5609, 1993
29. INK4 or Retinoblastoma Protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 55: 4833-4836, 1995
30. Louis DN, Gusella JF: A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 11: 412-415, 1995
31. Milev P, Friedlander DR, Sakurai T, Karthikeyan L, Flad M, Margolis RK, Grumet M, Margolis RU: Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J Cell Biol 127: 1703-1715, 1994
32. Peles E, Nativ M, Campbell PL, Sakurai T, Martinez R, Lev S, Clary DO, Schilling J, Barnea G, Plowman GD, Grumet M, Schlessinger J: The carbonic anhydrase domain of receptor tyrosine phosphatase β is a functional ligand for the axonal cell recognition molecule contactin. Cell 82: 251-260, 1995
33. Reyes-Mugica M, Rieger-Christ K, Ohgaki H, Ekstrand BC, Helie M, Kleinman G, Yahanda A, Fearon ER, Kleihues P, Reale MA: Loss of DCC expression and glioma progression. Cancer Res 57: 382-386, 1997
34. Mooney RA, Freund GG, Way BA, Bordwell KL: Expression of a transmembrane phosphotyrosine phosphatase inhibits cellular response to platelet-derived growth factor and insulin-like growth factor-1. J Biol Chem 267: 23443-23446, 1992
35. Faure R, Vincent M, Dufour M, Shaver A, Posner BI: Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line. J Cell Biochem 59: 389-401, 1995
36. Fischer EH, Charbonneau H, Tonks NK: Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 253: 401-406, 1991